Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 3, Pages 497-519
http://dx.doi.org/10.1100/tsw.2003.39
Mini-Review Article

Genetics of Early-Onset Alzheimer Dementia

Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), University of Antwerp, Antwerpen, Belgium

Academic Editor: Rudy Tanzi

Copyright © 2003 Rosa Rademakers et al.

Citations to this Article [30 citations]

The following is the list of published articles that have cited the current article.

  • Joanna L. Jankowsky, Hilda H. Slunt, Victoria Gonzales, Alena V. Savonenko, Jason C. Wen, Nancy A. Jenkins, Neal G. Copeland, Linda H. Younkin, Henry A. Lester, Steven G. Younkin, and David R. Borchelt, “Persistent Amyloidosis following Suppression of Aβ Production in a Transgenic Model of Alzheimer Disease,” PLoS Medicine, vol. 2, no. 12, pp. e355, 2005. View at Publisher · View at Google Scholar
  • Krzysztof Jozwiak, Cezary Zekanowski, and Slawomir Filipek, “Linear patterns of Alzheimer's disease mutations along α-helices of presenilins as a tool for PS-1 model construction,” Journal of Neurochemistry, vol. 98, no. 5, pp. 1560–1572, 2006. View at Publisher · View at Google Scholar
  • M. Grazina, J. Pratas, F. Silva, S. Oliveira, I. Santana, and C. Oliveira, “Genetic basis of Alzheimer's dementia: role of mtDNA mutations,” Genes, Brain and Behavior, vol. 5, pp. 92–107, 2006. View at Publisher · View at Google Scholar
  • Pertti Panula, Ville Sallinen, Maria Sundvik, Juha Kolehmainen, Veera Torkko, Anu Tiittula, Maxim Moshnyakov, and Piotr Podlasz, “Modulatory Neurotransmitter Systems and Behavior: Towards Zebrafish Models of Neurodegenerative Diseases,” Zebrafish, vol. 3, no. 2, pp. 235–247, 2006. View at Publisher · View at Google Scholar
  • Tamsin M. Wright, “Tramiprosate,” Drugs of Today, vol. 42, no. 5, pp. 291–298, 2006. View at Publisher · View at Google Scholar
  • M Grazina, J Pratas, F Silva, S Oliveira, I Santana, and C Oliveira, “Genetic basis of Alzheimer's dementia: role of mtDNA mutations,” Genes Brain And Behavior, vol. 5, pp. 92–107, 2006. View at Publisher · View at Google Scholar
  • George P. Vogler, “Behavior Genetics and Aging,” Handbook of the Psychology of Aging, pp. 41–55, 2006. View at Publisher · View at Google Scholar
  • Simon Wells, Cristi L. Stoick-Cooper, Ben Tucker, Ralph Martins, Svanhild Nornes, Morgan Newman, Giuseppe Verdile, Inna Frederich-Sleptsova, and Michael Lardelli, “Interference with splicing of presenilin transcripts has potent dominant negative effects on presenilin activity,” Human Molecular Genetics, vol. 17, no. 3, pp. 402–412, 2008. View at Publisher · View at Google Scholar
  • Yue Wang, Nigel H. Greig, Qian-sheng Yu, and Mark P. Mattson, “Presenilin-1 mutation impairs cholinergic modulation of synaptic plasticity and suppresses NMDA currents in hippocampus slices,” Neurobiology of Aging, vol. 30, no. 7, pp. 1061–1068, 2009. View at Publisher · View at Google Scholar
  • M.A. Nalls, B.J. Traynor, L. Launer, J. Hardy, R.J. Guerreiro, J. Simon-Sanchez, J.T. Bras, J.R. Gibbs, and A.B. Singleton, “Extended tracts of homozygosity identify novel candidate genes associated with late-onset Alzheimer's disease,” Neurogenetics, vol. 10, no. 3, pp. 183–190, 2009. View at Publisher · View at Google Scholar
  • R.J. Guerreiro, C. Paisán-Ruiz, R. Blesa, J. Hardy, J. Clarimón, R. Djaldetti, A. Lleó, J.L. Molinuevo, T. Gómez-Isla, and A. Singleton, “Whole genome analysis in a consanguineous family with early onset Alzheimer's disease,” Neurobiology of Aging, vol. 30, no. 12, pp. 1986–1991, 2009. View at Publisher · View at Google Scholar
  • Allan Jones, Philipp Kulozik, Anke Ostertag, and Stephan Herzig, “Common Pathological Processes and Transcriptional Pathways in Alzheimer's Disease and Type 2 Diabetes,” Journal Of Alzheimers Disease, vol. 16, no. 4, pp. 787–808, 2009. View at Publisher · View at Google Scholar
  • Luigi Bergamaschini, Emanuela Rossi, Carlo Vergani, and Maria Grazia De Simoni, “Alzheimer's Disease: Another Target for Heparin Therapy,” Thescientificworldjournal, vol. 9, pp. 891–908, 2009. View at Publisher · View at Google Scholar
  • Rita J. Guerreiro, Nicole Washecka, John Hardy, and Andrew Singleton, “A Thorough Assessment of Benign Genetic Variability in GRN and MAPT,” Human Mutation, vol. 31, no. 2, pp. E1126–E1140, 2010. View at Publisher · View at Google Scholar
  • Rita J. Guerreiro, Deborah R. Gustafson, and John Hardy, “The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE,” Neurobiology Of Aging, vol. 33, no. 3, pp. 437–456, 2012. View at Publisher · View at Google Scholar
  • N. El Kadmiri, K. Hamzi, B. El Moutawakil, I. Slassi, and S. Nadifi, “Les aspects génétiques de la maladie d’Alzheimer (Revue),” Pathologie Biologie, 2013. View at Publisher · View at Google Scholar
  • Houshang Amiri, Kolsoum Saeidi, Parvin Borhani, Arash Manafirad, Mahdi Ghavami, and Valerio Zerbi, “Alzheimer’s Disease: Pathophysiology and Applications of Magnetic Nanoparticles as MRI Theranostic Agents,” ACS Chemical Neuroscience, pp. 130911163658007, 2013. View at Publisher · View at Google Scholar
  • Benoît Leclerc, and Abedelnasser Abulrob, “Perspectives in Molecular Imaging Using Staging Biomarkers and Immunotherapies in Alzheimer’s Disease,” The Scientific World Journal, vol. 2013, pp. 1–16, 2013. View at Publisher · View at Google Scholar
  • N. El Kadmiri, Y. Zaid, K. Hamzi, S. Nadifi, I. Slassi, and B. El Moutawakil, “Présentation clinique de cas marocains atteints de la maladie d’Alzheimer,” L'Encéphale, 2014. View at Publisher · View at Google Scholar
  • Joseph H. Lee, Amanda Kahn, Rong Cheng, Christiane Reitz, Badri Vardarajan, Rafael Lantigua, Martin Medrano, Ivonne Z. Jiménez-Velázquez, Jennifer Williamson, Peter Nagy, and Richard Mayeux, “Disease-related mutations among Caribbean Hispanics with familial dementia,” Molecular Genetics & Genomic Medicine, 2014. View at Publisher · View at Google Scholar
  • J. Nyberg, M. A. I. Aberg, L. Schioler, M. Nilsson, A. Wallin, K. Toren, and H. G. Kuhn, “Cardiovascular and cognitive fitness at age 18 and risk of early-onset dementia,” Brain, 2014. View at Publisher · View at Google Scholar
  • Rene Rodriguez, Francisco Lopera, Alfredo Alvarez, Yuriem Fernandez, Lidice Galan, Yakeel Quiroz, and Maria Antonieta Bobes, “Spectral Analysis of EEG in Familial Alzheimer’s Disease with E280A Presenilin-1 Mutation Gene,” International Journal of Alzheimer's Disease, vol. 2014, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Eva Bagyinszky, Young Chul Youn, and Seong Soo A. An, “The genetics of Alzheimer's disease,” Clinical Interventions in Aging, vol. 9, pp. 535–551, 2014. View at Publisher · View at Google Scholar
  • Yan Cai, Seong Soo A. An, and SangYun Kim, “Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders,” Clinical Interventions In Aging, vol. 10, pp. 1163–1172, 2015. View at Publisher · View at Google Scholar
  • T.C Foster, C. Kyritsopoulos, and A. Kumar, “Central role for NMDA receptors in redox mediated impairment of synaptic function during aging and Alzheimer’s disease,” Behavioural Brain Research, 2016. View at Publisher · View at Google Scholar
  • John Noel M. Viaña, Merlin Bittlinger, and Frederic Gilbert, “Ethical Considerations for Deep Brain Stimulation Trials in Patients with Early-Onset Alzheimer’s Disease,” Journal of Alzheimer's Disease, pp. 1–13, 2017. View at Publisher · View at Google Scholar
  • Ana Hategan, and Glen L. Xiong, “Major or Mild Neurocognitive Disorder Due to Alzheimer Disease,” Geriatric Psychiatry, pp. 369–401, 2017. View at Publisher · View at Google Scholar
  • Ana Hategan, James A. Bourgeois, Tracy Cheng, Julie Young, Ana Hategan, James A. Bourgeois, Tracy Cheng, and Julie Young, “Common Major and Mild Neurocognitive Disorders: Alzheimer Disease, Frontotemporal, Lewy Body, and Vascular Types,” Geriatric Psychiatry Study Guide, pp. 203–242, 2018. View at Publisher · View at Google Scholar
  • Rupkatha Banerjee, Zoe Rudloff, Crystal Naylor, Michael C Yu, and Shermali Gunawardena, “The presenilin loop region is essential for glycogen synthase kinase 3 β (GSK3β) mediated functions on motor proteins during axonal transport,” Human Molecular Genetics, 2018. View at Publisher · View at Google Scholar
  • Avijit Podder, Mansi Pandit, and Latha Narayanan, “Drug Target Prioritization for Alzheimer's Disease Using Protein Interaction Network Analysis,” OMICS: A Journal of Integrative Biology, vol. 22, no. 10, pp. 665–677, 2018. View at Publisher · View at Google Scholar